Ishares IV PLC (BTEC) Share Price & Analysis

No recent announcements

30 Sep 2026	Publication of iShares IV pl Annual Financial Report
30 Sep 2025	iShares IV plc Annual report and audited financial statements
30 Sep 2024	iShares IV plc Annual Financial and Audited Report & Accounts

An exchange-traded fund, managed by iShares, that tracks the Nasdaq US Biotechnology index, accumulating income.

ISIN: IE00BYXG2H39
Exchange: XLON
Market: Main Market
Market Segment: EUET
Market Sector: UET5
Security Description: iShares NASDAQ US Biotechnology UCITS ETF, USD (Acc) Share Class of No Par Value; fully paid
Listing Category: Open-ended investment companies

No recent announcements

30 Sep 2026	Publication of iShares IV pl Annual Financial Report
30 Sep 2025	iShares IV plc Annual report and audited financial statements
30 Sep 2024	iShares IV plc Annual Financial and Audited Report & Accounts

An exchange-traded fund, managed by iShares, that tracks the Nasdaq US Biotechnology index, accumulating income.

ISIN: IE00BYXG2H39
Exchange: XLON
Market: Main Market
Market Segment: EUET
Market Sector: UET5
Security Description: iShares NASDAQ US Biotechnology UCITS ETF, USD (Acc) Share Class of No Par Value; fully paid
Listing Category: Open-ended investment companies

Ishares IV PLC